Contraceptive patch (English Wikipedia)

Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW (February 2002). "A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra)". Fertility and Sterility. 77 (2 Suppl 2): S19–S26. doi:10.1016/S0015-0282(01)03264-2. PMID 11849632.
Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW (February 2002). "Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data". Fertility and Sterility. 77 (2 Suppl 2): S13–S18. doi:10.1016/S0015-0282(01)03275-7. PMID 11849631.
Cole JA, Norman H, Doherty M, Walker AM (February 2007). "Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users". Obstetrics and Gynecology. 109 (2 Pt 1): 339–346. doi:10.1097/01.AOG.0000250968.82370.04. PMID 17267834. S2CID 1572286.
Jick S, Kaye JA, Li L, Jick H (July 2007). "Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol". Contraception. 76 (1): 4–7. doi:10.1016/j.contraception.2007.03.003. PMID 17586129.
Pitsavos C, Stefanadis C, Toutouzas P (2000). "Contraception in women at high risk or with established cardiovascular disease". Annals of the New York Academy of Sciences. 900 (1): 215–227. Bibcode:2000NYASA.900..215P. doi:10.1111/j.1749-6632.2000.tb06233.x. PMID 10818409. S2CID 45035196.
Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ (June 2005). "Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial". Obstetrics and Gynecology. 105 (6): 1389–1396. doi:10.1097/01.AOG.0000160430.61799.f6. PMID 15932834. S2CID 8831803.
Rivera R, Yacobson I, Grimes D (November 1999). "The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". American Journal of Obstetrics and Gynecology. 181 (5 Pt 1): 1263–1269. doi:10.1016/S0002-9378(99)70120-1. PMID 10561657.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"Evra EPAR". European Medicines Agency. 17 September 2018. Retrieved 18 February 2020.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Pitsavos C, Stefanadis C, Toutouzas P (2000). "Contraception in women at high risk or with established cardiovascular disease". Annals of the New York Academy of Sciences. 900 (1): 215–227. Bibcode:2000NYASA.900..215P. doi:10.1111/j.1749-6632.2000.tb06233.x. PMID 10818409. S2CID 45035196.

lacrossetribune.com (Global: low place; English: 9,866^th place)

Schott K, Foley RJ (18 November 2005). "Family sues birth control maker over death of daughter, 14". The La Crosse Tribune. The Associated Press. Archived from the original on 26 October 2008.

mayoclinic.com (Global: 3,634^th place; English: 2,869^th place)

"Ortho Evra (Contraceptive Patch)". Mayo Clinic. 2010. Archived from the original on 15 October 2012. Retrieved 3 February 2011.

medicines.org.uk (Global: 3,823^rd place; English: 2,387^th place)

medicines.org.uk

"Evra transdermal patch - Summary of Product Characteristics (SmPC)". (emc). 26 June 2020. Archived from the original on 24 October 2020. Retrieved 4 July 2020.
"Evra transdermal patch - Summary of Product Characteristics (SmPC)". (emc). 29 November 2018. Archived from the original on 7 November 2017. Retrieved 17 February 2020.

emc.medicines.org.uk

Janssen-Cilag (January 26, 2007). "Evra Patient Information Leaflet (PIL)". Archived from the original on September 28, 2007. Retrieved 2007-07-20.

medpagetoday.com (Global: 9,274^th place; English: 5,856^th place)

Medpage Today. Evidence on Ortho Evra Patch Thrombosis Risk Is Contradictory Archived 2006-03-01 at the Wayback Machine. Published February 17, 2006.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW (February 2002). "A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra)". Fertility and Sterility. 77 (2 Suppl 2): S19–S26. doi:10.1016/S0015-0282(01)03264-2. PMID 11849632.
Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW (February 2002). "Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data". Fertility and Sterility. 77 (2 Suppl 2): S13–S18. doi:10.1016/S0015-0282(01)03275-7. PMID 11849631.
Cole JA, Norman H, Doherty M, Walker AM (February 2007). "Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users". Obstetrics and Gynecology. 109 (2 Pt 1): 339–346. doi:10.1097/01.AOG.0000250968.82370.04. PMID 17267834. S2CID 1572286.
Jick S, Kaye JA, Li L, Jick H (July 2007). "Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol". Contraception. 76 (1): 4–7. doi:10.1016/j.contraception.2007.03.003. PMID 17586129.
Pitsavos C, Stefanadis C, Toutouzas P (2000). "Contraception in women at high risk or with established cardiovascular disease". Annals of the New York Academy of Sciences. 900 (1): 215–227. Bibcode:2000NYASA.900..215P. doi:10.1111/j.1749-6632.2000.tb06233.x. PMID 10818409. S2CID 45035196.
Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ (June 2005). "Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial". Obstetrics and Gynecology. 105 (6): 1389–1396. doi:10.1097/01.AOG.0000160430.61799.f6. PMID 15932834. S2CID 8831803.
Rivera R, Yacobson I, Grimes D (November 1999). "The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". American Journal of Obstetrics and Gynecology. 181 (5 Pt 1): 1263–1269. doi:10.1016/S0002-9378(99)70120-1. PMID 10561657.

dailymed.nlm.nih.gov

"Xulane- norelgestromin and ethinyl estradiol patch". DailyMed. 19 April 2017. Retrieved 17 February 2020.

picaboo.biz (Global: low place; English: low place)

"What is spermicide?". Picaboo.biz. Archived from the original on 2020-07-28. Retrieved 2020-05-29.

plannedparenthood.org (Global: low place; English: low place)

"Birth Control Patch (Ortho Evra)". Planned Parenthood. 3 February 2011. Archived from the original on 11 April 2014. Retrieved 3 February 2011.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Cole JA, Norman H, Doherty M, Walker AM (February 2007). "Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users". Obstetrics and Gynecology. 109 (2 Pt 1): 339–346. doi:10.1097/01.AOG.0000250968.82370.04. PMID 17267834. S2CID 1572286.
Pitsavos C, Stefanadis C, Toutouzas P (2000). "Contraception in women at high risk or with established cardiovascular disease". Annals of the New York Academy of Sciences. 900 (1): 215–227. Bibcode:2000NYASA.900..215P. doi:10.1111/j.1749-6632.2000.tb06233.x. PMID 10818409. S2CID 45035196.
Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ (June 2005). "Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial". Obstetrics and Gynecology. 105 (6): 1389–1396. doi:10.1097/01.AOG.0000160430.61799.f6. PMID 15932834. S2CID 8831803.

web.archive.org (Global: 1^st place; English: 1^st place)

Trussell J (2011). "Contraceptive efficacy". In Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Kowal D, Policar MS (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2017-02-15 at the Wayback Machine
"Evra transdermal patch - Summary of Product Characteristics (SmPC)". (emc). 26 June 2020. Archived from the original on 24 October 2020. Retrieved 4 July 2020.
"FDA Approves Agile Therapeutics, Inc.'s Twirla (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin". Agile Therapeutics. 14 February 2020. Archived from the original on 29 January 2021. Retrieved 17 February 2020.
"Evra transdermal patch - Summary of Product Characteristics (SmPC)". (emc). 29 November 2018. Archived from the original on 7 November 2017. Retrieved 17 February 2020.
"Birth Control Patch (Ortho Evra)". Planned Parenthood. 3 February 2011. Archived from the original on 11 April 2014. Retrieved 3 February 2011.
Janssen-Cilag (January 26, 2007). "Evra Patient Information Leaflet (PIL)". Archived from the original on September 28, 2007. Retrieved 2007-07-20.
Medpage Today. Evidence on Ortho Evra Patch Thrombosis Risk Is Contradictory Archived 2006-03-01 at the Wayback Machine. Published February 17, 2006.
FDA Approves Update to Label on Birth Control Patch. FDA. January 18, 2008
"Ortho Evra (Contraceptive Patch)". Mayo Clinic. 2010. Archived from the original on 15 October 2012. Retrieved 3 February 2011.
"What is spermicide?". Picaboo.biz. Archived from the original on 2020-07-28. Retrieved 2020-05-29.
Schott K, Foley RJ (18 November 2005). "Family sues birth control maker over death of daughter, 14". The La Crosse Tribune. The Associated Press. Archived from the original on 26 October 2008.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Trussell J (2011). "Contraceptive efficacy". In Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Kowal D, Policar MS (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2017-02-15 at the Wayback Machine

yourlawyer.com (Global: low place; English: low place)

Tim (2006-10-26). "FDA warns of contraceptive patch dangers - Parker & Waichman". Parker Waichman LLP. Retrieved 2024-04-06.

Contraceptive patch (English Wikipedia)

agiletherapeutics.com (Global: low place; English: low place)

ir.agiletherapeutics.com

archive.org (Global: 6th place; English: 6th place)

canada.ca (Global: 1,712th place; English: 1,063rd place)

health-products.canada.ca

contraceptivetechnology.com (Global: low place; English: low place)

contraceptivetechnology.org (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

europa.eu (Global: 68th place; English: 117th place)

ema.europa.eu

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

lacrossetribune.com (Global: low place; English: 9,866th place)

mayoclinic.com (Global: 3,634th place; English: 2,869th place)

medicines.org.uk (Global: 3,823rd place; English: 2,387th place)

medicines.org.uk

emc.medicines.org.uk

medpagetoday.com (Global: 9,274th place; English: 5,856th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

picaboo.biz (Global: low place; English: low place)

plannedparenthood.org (Global: low place; English: low place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

yourlawyer.com (Global: low place; English: low place)

archive.org (Global: 6^th place; English: 6^th place)

canada.ca (Global: 1,712^th place; English: 1,063^rd place)

doi.org (Global: 2^nd place; English: 2^nd place)

europa.eu (Global: 68^th place; English: 117^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

lacrossetribune.com (Global: low place; English: 9,866^th place)

mayoclinic.com (Global: 3,634^th place; English: 2,869^th place)

medicines.org.uk (Global: 3,823^rd place; English: 2,387^th place)

medpagetoday.com (Global: 9,274^th place; English: 5,856^th place)

nih.gov (Global: 4^th place; English: 4^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)